Abstract
Takayasu arteritis (TA) and Crohn’s disease (CD) are chronic inflammatory diseases with granulomatous nature. Here, we report a case of TA with a silent course of CD who was refractory to corticosteroid and immunosuppressive treatments and improved with adalimumab therapy.
References
Takayasu’s arteritis (2009) EULAR on line course on rheumatic disease
Bernstein CN, Blanchard JF (1999) The epidemiology of Crohn’s disease. Gastroenterology 116:1503–1504
Reny JL, Paul JF, Lefebvre C et al (2003) Association of Takayasu’s arteritis and Crohn’s disease; results of a study on 44 Takayasu patients and review of the literature. Ann Med Intern 154:85–90
Levitsky J, Harrison JR, Cohen RD (2002) Crohn’s disease and Takayasu’s arteritis. J Clin Gastroenterol 34:454–456
Lenhoff SJ, Mee AS (1982) Crohn’s disease of the colon with Takayasu’s arteritis. Postgrad Med J 58:386–389
Farrant M, Mason JC, Wong NA, Longman RJ (2008) Takayasu’s arteritis following Crohn’s disease in a young woman: any evidence for a common pathogenesis? World J Gastroenterol 14:4087–4090
De Simone M, Cioffi U, Quatrini M et al (2006) Crohn’s disease and Takayasu’s arteritis: is this association difficult to find out? Minerva Gastroenterol Dietol 52:441–443
Comarmond C, Plaisier E, Dahan K et al. (2011) Anti TNF-α in refractory Takayasu’s arteritis: cases series and review of the literature. Autoimmun Rev (Epub Dec 4)
Molloy ES, Langford CA, Clark TM, Gota CE, Hoffman GS (2008) Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann Rheum Dis 67:1567–1569
Tatò F, Rieger J, Hoffmann U (2005) Refractory Takayasu’s arteritis successfully treated with the human, monoclonal anti-tumor necrosis factor antibody adalimumab. Int Angiol 24:304–307
Wasan SK, Kane SV (2011) Adalimumab for the treatment of inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 5:679–684
Cottone M, Criscuoli V (2011) Infliximab to treat Crohn’s disease: an update. Clin Exp Gastroenterol 4:227–238
Sandborn WJ, Hanauer SB, Katz S et al (2001) Etanercept for active Crohn’s disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology 121:1088–1094
Osman M, Aaron S, Noga M, Yacyshyn E (2011) Takayasu’s arteritis progression on anti-TNF biologics: a case series. Clin Rheumatol 30:703–706 (Epub Jan 2011)
Katoh N, Kubota M, Shimojima Y et al (2010) Takayasu’s arteritis in a patient with Crohn’s disease: an unexpected association during infliximab therapy. Intern Med 49:179–182
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yilmaz, N., Can, M., Alibaz-Oner, F. et al. Clinically silent Crohn’s disease in a patient with Takayasu’s Arteritis unresponsive to conventional therapies. Rheumatol Int 33, 3091–3093 (2013). https://doi.org/10.1007/s00296-012-2558-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-012-2558-2